187 related articles for article (PubMed ID: 17989510)
1. Comparison of nitric oxide synthase inhibitors, phospholipase A2 inhibitor and free radical scavengers as attenuators of opioid withdrawal syndrome.
Mori T; Ito S; Matsubayashi K; Sawaguchi T
Behav Pharmacol; 2007 Dec; 18(8):725-9. PubMed ID: 17989510
[TBL] [Abstract][Full Text] [Related]
2. Inhibitors of nitric oxide synthase and the opioid withdrawal syndrome.
London ED; Kimes AS; Vaupel DB
NIDA Res Monogr; 1995; 147():170-81. PubMed ID: 8742786
[TBL] [Abstract][Full Text] [Related]
3. Attenuation of morphine tolerance and dependence by aminoguanidine in mice.
Abdel-Zaher AO; Hamdy MM; Aly SA; Abdel-Hady RH; Abdel-Rahman S
Eur J Pharmacol; 2006 Jul; 540(1-3):60-6. PubMed ID: 16730698
[TBL] [Abstract][Full Text] [Related]
4. Cross talk between nitric oxide and ERK1/2 signaling pathway in the spinal cord mediates naloxone-precipitated withdrawal in morphine-dependent rats.
Cao JL; Liu HL; Wang JK; Zeng YM
Neuropharmacology; 2006 Aug; 51(2):315-26. PubMed ID: 16712881
[TBL] [Abstract][Full Text] [Related]
5. Nitric oxide synthase inhibitors. Preclinical studies of potential use for treatment of opioid withdrawal.
Vaupel DB; Kimes AS; London ED
Neuropsychopharmacology; 1995 Dec; 13(4):315-22. PubMed ID: 8747756
[TBL] [Abstract][Full Text] [Related]
6. Comparison of 7-nitroindazole with other nitric oxide synthase inhibitors as attenuators of opioid withdrawal.
Vaupel DB; Kimes AS; London ED
Psychopharmacology (Berl); 1995 Apr; 118(4):361-8. PubMed ID: 7568621
[TBL] [Abstract][Full Text] [Related]
7. Comparison of simultaneous administration of lithium with L-NAME or L-arginine on morphine withdrawal syndrome in mice.
Dehpour AR; Sadr SS; Nouroddini M; Shadan F; Nourozi A; Farahani M; Sahebgharani M
Hum Psychopharmacol; 2000 Mar; 15(2):87-93. PubMed ID: 12404337
[TBL] [Abstract][Full Text] [Related]
8. Nitric oxide synthase inhibitors attenuate acute and chronic morphine withdrawal response in the rat locus coeruleus: an in vivo voltammetric study.
Hall S; Milne B; Jhamandas K
Brain Res; 1996 Nov; 739(1-2):182-91. PubMed ID: 8955938
[TBL] [Abstract][Full Text] [Related]
9. Nuclear factor-kappa-B inhibitor modulates the development of opioid dependence in a mouse model of naloxone-induced opioid withdrawal syndrome.
Rehni AK; Bhateja P; Singh TG; Singh N
Behav Pharmacol; 2008 May; 19(3):265-9. PubMed ID: 18469544
[TBL] [Abstract][Full Text] [Related]
10. Effect of agmatine on brain L-citrulline production during morphine withdrawal in rats: a microdialysis study in nucleus accumbens.
Yananli H; Gören MZ; Berkman K; Aricioğlu F
Brain Res; 2007 Feb; 1132(1):51-8. PubMed ID: 17182008
[TBL] [Abstract][Full Text] [Related]
11. Possible involvement of nitric oxide in morphine-induced miosis and reduction of intraocular pressure in rabbits.
Bonfiglio V; Bucolo C; Camillieri G; Drago F
Eur J Pharmacol; 2006 Mar; 534(1-3):227-32. PubMed ID: 16516192
[TBL] [Abstract][Full Text] [Related]
12. Effects of nitric oxide synthase inhibitors in attenuating nicotine withdrawal in rats.
Jain R; Mukherjee K; Mohan D
Pharmacol Biochem Behav; 2008 Feb; 88(4):473-80. PubMed ID: 18031800
[TBL] [Abstract][Full Text] [Related]
13. Endogenous nitric oxide modulates naloxone-precipitated withdrawal signs in a mouse model with acute cholestasis.
Dehpour AR; Akbarloo N; Ghafourifar P
Behav Pharmacol; 1998 Feb; 9(1):77-80. PubMed ID: 9832951
[TBL] [Abstract][Full Text] [Related]
14. Possible mechanisms of action in quercetin reversal of morphine tolerance and dependence.
Naidu PS; Singh A; Joshi D; Kulkarni SK
Addict Biol; 2003 Sep; 8(3):327-36. PubMed ID: 13129835
[TBL] [Abstract][Full Text] [Related]
15. Attenuation of withdrawal-induced hyperactivity of locus coeruleus neurones by inhibitors of nitric oxide synthase in morphine-dependent rats.
Pineda J; Torrecilla M; Martín-Ruiz R; Ugedo L
Neuropharmacology; 1998 Jun; 37(6):759-67. PubMed ID: 9707290
[TBL] [Abstract][Full Text] [Related]
16. Morphine-induced antinociception in the formalin test: sensitization and interactions with D1 and D2 dopamine receptors and nitric oxide agents.
Zarrindast MR; Asgari-Afshar A; Sahebgharani M
Behav Pharmacol; 2007 May; 18(3):177-84. PubMed ID: 17426481
[TBL] [Abstract][Full Text] [Related]
17. Correlation between inhibitions of morphine withdrawal and nitric-oxide synthase by agmatine.
Li J; Li X; Pei G; Qin BY
Zhongguo Yao Li Xue Bao; 1999 Apr; 20(4):375-80. PubMed ID: 10452129
[TBL] [Abstract][Full Text] [Related]
18. The effects of simultaneous administration of alpha(2) -adrenergic agents with L-NAME or L-arginine on the development and expression of morphine dependence in mice.
Zarrindast MR; Homayoun H; Khavandgar S; Fayaz-Dastgerdi M; Fayaz-Dastgerdi M
Behav Pharmacol; 2002 Mar; 13(2):117-25. PubMed ID: 11981224
[TBL] [Abstract][Full Text] [Related]
19. [Effect of nitric oxide synthase inhibitor on the testis cell apoptosis in morphine-dependent rats].
Li J; Yan B; Liu Y
Zhonghua Nan Ke Xue; 2004 Nov; 10(11):836-40. PubMed ID: 15595686
[TBL] [Abstract][Full Text] [Related]
20. Involvement of supraspinal and peripheral naloxonazine-insensitive opioid receptor sites in the expression of μ-opioid receptor agonist-induced physical dependence.
Mori T; Komiya S; Uzawa N; Inoue K; Itoh T; Aoki S; Shibasaki M; Suzuki T
Eur J Pharmacol; 2013 Sep; 715(1-3):238-45. PubMed ID: 23707904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]